Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

BACKGROUND: Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was to examine the clinical and psychological factors associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalbeth, Nicola, House, Meaghan E, Horne, Anne, Petrie, Keith J, McQueen, Fiona M, Taylor, William J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493372/
https://www.ncbi.nlm.nih.gov/pubmed/22978848
http://dx.doi.org/10.1186/1471-2474-13-174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493372/
https://www.ncbi.nlm.nih.gov/pubmed/22978848
http://dx.doi.org/10.1186/1471-2474-13-174

Ejemplares similares